Feasibility of Fibroscan in Assessment of Hepatic Steatosis and Fibrosis in Obese Patients: Report From a General Internal Medicine Clinic

AVCU A., Kaya E., YILMAZ Y.

TURKISH JOURNAL OF GASTROENTEROLOGY, vol.32, no.5, pp.466-472, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 5
  • Publication Date: 2021
  • Doi Number: 10.5152/tjg.2021.20498
  • Journal Name: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Page Numbers: pp.466-472
  • Keywords: Obesity, fatty liver, fibrosis, metabolic syndrome, FATTY LIVER-DISEASE, CONTROLLED ATTENUATION PARAMETER, BARIATRIC SURGERY CANDIDATES, TRANSIENT ELASTOGRAPHY, STIFFNESS MEASUREMENT, DIAGNOSTIC-ACCURACY, XL PROBE, ASSOCIATION, PREVALENCE, CAP
  • Recep Tayyip Erdoğan University Affiliated: No

Abstract

Background: In metabolic associated fatty liver disease (MAFLD) vibration controlled transient elastography (VCTE) by Fibroscan has emerged as a non-invasive diagnostic tool for the measurement of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), which are surrogate markers for hepatic steatosis and fibrosis, respectively. However, obesity constitutes a limitation in terms of creating unreliable examinations due to increased skin to liver capsule distance. Here, we aimed to investigate the feasibility of VCTE in the evaluation of hepatic steatosis and fibrosis in obese individuals.